- Home
- CNXN vs VRDN Comparison
CNXN vs VRDN Comparison
Compare CNXN & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNXN
- VRDN
- Stock Information
- Founded
- CNXN 1982
- VRDN 2006
- Country
- CNXN United States
- VRDN United States
- Employees
- CNXN N/A
- VRDN N/A
- Industry
- CNXN Catalog/Specialty Distribution
- VRDN Medical Specialities
- Sector
- CNXN Consumer Discretionary
- VRDN Health Care
- Exchange
- CNXN Nasdaq
- VRDN Nasdaq
- Market Cap
- CNXN 1.6B
- VRDN 1.6B
- IPO Year
- CNXN 1998
- VRDN N/A
- Fundamental
- Price
- CNXN $60.97
- VRDN $23.63
- Analyst Decision
- CNXN
- VRDN Strong Buy
- Analyst Count
- CNXN 0
- VRDN 10
- Target Price
- CNXN N/A
- VRDN $36.78
- AVG Volume (30 Days)
- CNXN 74.6K
- VRDN 1.5M
- Earning Date
- CNXN 10-29-2025
- VRDN 11-13-2025
- Dividend Yield
- CNXN 0.98%
- VRDN N/A
- EPS Growth
- CNXN N/A
- VRDN N/A
- EPS
- CNXN 3.24
- VRDN N/A
- Revenue
- CNXN $2,878,704,000.00
- VRDN $305,000.00
- Revenue This Year
- CNXN $7.92
- VRDN N/A
- Revenue Next Year
- CNXN $5.82
- VRDN $34,044.63
- P/E Ratio
- CNXN $18.82
- VRDN N/A
- Revenue Growth
- CNXN 3.19
- VRDN 5.90
- 52 Week Low
- CNXN $55.50
- VRDN $9.90
- 52 Week High
- CNXN $75.84
- VRDN $27.20
- Technical
- Relative Strength Index (RSI)
- CNXN 46.24
- VRDN 62.01
- Support Level
- CNXN $56.06
- VRDN $21.65
- Resistance Level
- CNXN $62.56
- VRDN $24.23
- Average True Range (ATR)
- CNXN 1.33
- VRDN 1.11
- MACD
- CNXN -0.02
- VRDN -0.03
- Stochastic Oscillator
- CNXN 68.86
- VRDN 68.07
About CNXN PC Connection Inc.
PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).